Finding out you’re sick is hard enough. Finding out you have a disease shared by less than 1% of the population with no established treatment is something else entirely. Rare disease breaks the ...
Last year was characterized by fewer but larger venture capital financings for biotech, with 2025’s top 10 private rounds bringing in nearly $4 billion collectively. As venture markets rebounded ...
Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...
Business by LA Times Studios presents a list of Southern California life science firms ranked by the number of employees in Southern California, including Ventura, Los Angeles, Orange, San Bernardino, ...
CRISPR stocks offer high growth potential but are volatile and risky, suitable for aggressive investors. Beam Therapeutics uses a precise base-editing technique, differentiating it from other CRISPR ...
Alzheimer gehört zu den meistgefürchteten Alterserkrankungen. Ein neuer Selbsttest von Ärzten der Uni München liefert Orientierung. Rund 1,8 Millionen Menschen leben in Deutschland mit einer ...